Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Cancer. 2010 Jun 15;116(12):3061-70. doi: 10.1002/cncr.25045.
Refusal of appropriately indicated do-not-resuscitate (DNR) orders may cause harm and distress for patients, families, and the medical team. We conducted a retrospective study to determine the frequency and predictors of refusals of DNR in advanced cancer patients admitted to an acute palliative care unit.
A total of 2538 consecutive admissions were reviewed. Demographic and clinical characteristics from 200 consecutive patients with DNR orders and 100 consecutive patients who refused DNR were collected, and differences between the groups were determined by multivariate regression and recursive partitioning analysis.
Of 2538 admissions, 2530 (99%) were appropriate for DNR discussion. Of the 2530 admissions, 2374 were unique patients, and 100 (4%) of 2374 refused DNR. Refusers had median (interquartile range, IQR) pain of 7 (4-9) versus 5 (3-8, P = .0005), nausea of 2 (0-7) versus 1 (0-4, P = .05), and dyspnea of 1 (0-5) versus 4 (0-7, P = .002) as compared with DNR nonrefusers, respectively. Patients with hematological malignancies and advance directives had a lower DNR refusal risk (odds ratio [OR], 0.38; P = .02, and OR, 0.36; P < .0001, respectively). Multivariate regression analysis revealed that patients with moderate-severe pain (OR, 3.19; P = .002) and with no advance directives (OR, 2.94; P < or = .001) had higher DNR refusal risk. There were more inpatient deaths among DNR nonrefusers (87 of 200 vs 1 of 100, P < .0001). Median (IQR) time from discharge to death was 18 (8-35) days for those with DNR orders and 85 (25-206) days for DNR refusers (P < or = .0001).
DNR refusal in patients admitted to the acute palliative care unit is low, more frequent in patients with more pain and nausea and no advance directives, and associated with longer survival. This study demonstrates possible predictors of complicated DNR discussions.
拒绝适当指示的不复苏(DNR)可能会给患者、家属和医疗团队带来伤害和困扰。我们进行了一项回顾性研究,以确定在急性姑息治疗病房住院的晚期癌症患者中 DNR 拒绝的频率和预测因素。
共回顾了 2538 例连续入院病例。收集了 200 例有 DNR 医嘱的患者和 100 例拒绝 DNR 的患者的 200 例连续入院的人口统计学和临床特征,并通过多元回归和递归分区分析确定组间差异。
在 2538 例入院病例中,2530 例(99%)适合进行 DNR 讨论。在 2530 例入院病例中,2374 例为独特患者,其中 100 例(4%)拒绝 DNR。拒绝者的中位(四分位距,IQR)疼痛为 7(4-9),而 DNR 非拒绝者为 5(3-8,P=0.0005),恶心为 2(0-7),而 DNR 非拒绝者为 1(0-4,P=0.05),呼吸困难为 1(0-5),而 DNR 非拒绝者为 4(0-7,P=0.002)。患有血液恶性肿瘤和预先指示的患者 DNR 拒绝风险较低(比值比 [OR],0.38;P=0.02 和 OR,0.36;P<.0001)。多变量回归分析显示,中重度疼痛(OR,3.19;P=0.002)和无预先指示(OR,2.94;P<.001)的患者 DNR 拒绝风险更高。DNR 非拒绝者的住院内死亡率更高(200 例中有 87 例,100 例中有 1 例,P<.0001)。有 DNR 医嘱的患者从出院到死亡的中位(IQR)时间为 18(8-35)天,而 DNR 拒绝者为 85(25-206)天(P<.0001)。
在急性姑息治疗病房住院的患者中,DNR 拒绝率较低,疼痛和恶心更严重且无预先指示的患者更频繁拒绝 DNR,并且与更长的生存时间相关。这项研究表明了可能存在复杂的 DNR 讨论的预测因素。